July 12, 2024 — Reuters has a news flash for us. People are quick to quit taking GLP-1 medicines. In an “exclusive” story, the Reuters report comes from a analysis from Prime Therapeutics and Magellan Rx (Prime/MRx) – a pharmacy benefit manager (PBM). The headline finding is that 85% of people who start on GLP-1 medicines have quit taking […]
May 30, 2024 — In a world that systematically denies people access to obesity medicines, the rush of reports that people frequently stop taking them makes us wonder. How does this qualify as news? Why do reporters repeatedly paint a misleading picture of non-compliant patients? Yet, health reporters keep offering up this narrative. The latest prompt for this is […]
June 22, 2023 — It can be tedious. But the truth is that persistent pursuit of access to obesity care does indeed bring incremental progress. The latest case study came this week in Connecticut, with Governor Ned Lamont signing a bill into law to provide better access to obesity care under the state’s Medicaid program. Years of Effort This […]
March 14, 2023 — Recently, we have written much about the high cost of obesity medicines, limited coverage under health plans, and the need for change. This is a very real problem and glaciers melt faster (sad to say) than policy makers make progress on this. But absurd arguments about the cost of obesity care do not help. In […]
January 12, 2021 — Isaac Bashevis Singer told us we must believe in free will – there is no other choice. Thus, many of us put a great deal of energy into resolutions at this time of year. Often, they involve an effort to eat more healthfully. Resolve fades. Though 77 percent of resolutions last for at least a […]
